Free Trial

Exicure (XCUR) Competitors

Exicure logo
$5.09 -0.01 (-0.20%)
Closing price 04:00 PM Eastern
Extended Trading
$5.14 +0.05 (+0.96%)
As of 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

XCUR vs. ATRA, MGNX, COYA, BMEA, WHWK, HLVX, MEIP, CNTX, ADVM, and ALXO

Should you be buying Exicure stock or one of its competitors? The main competitors of Exicure include Atara Biotherapeutics (ATRA), MacroGenics (MGNX), Coya Therapeutics (COYA), Biomea Fusion (BMEA), Whitehawk Therapeutics (WHWK), HilleVax (HLVX), MEI Pharma (MEIP), Context Therapeutics (CNTX), Adverum Biotechnologies (ADVM), and ALX Oncology (ALXO). These companies are all part of the "pharmaceutical products" industry.

Exicure vs. Its Competitors

Atara Biotherapeutics (NASDAQ:ATRA) and Exicure (NASDAQ:XCUR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Atara Biotherapeutics currently has a consensus price target of $21.00, indicating a potential upside of 37.43%. Given Atara Biotherapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Atara Biotherapeutics is more favorable than Exicure.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Atara Biotherapeutics
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.50
Exicure
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Atara Biotherapeutics has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500. Comparatively, Exicure has a beta of 3.76, suggesting that its share price is 276% more volatile than the S&P 500.

In the previous week, Atara Biotherapeutics had 2 more articles in the media than Exicure. MarketBeat recorded 3 mentions for Atara Biotherapeutics and 1 mentions for Exicure. Exicure's average media sentiment score of 0.95 beat Atara Biotherapeutics' score of 0.73 indicating that Exicure is being referred to more favorably in the news media.

Company Overall Sentiment
Atara Biotherapeutics Positive
Exicure Positive

Atara Biotherapeutics has a net margin of 3.07% compared to Exicure's net margin of 0.00%. Atara Biotherapeutics' return on equity of -8.34% beat Exicure's return on equity.

Company Net Margins Return on Equity Return on Assets
Atara Biotherapeutics3.07% -8.34% 6.61%
Exicure N/A -192.16%-84.30%

70.9% of Atara Biotherapeutics shares are held by institutional investors. Comparatively, 42.8% of Exicure shares are held by institutional investors. 4.0% of Atara Biotherapeutics shares are held by company insiders. Comparatively, 52.8% of Exicure shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Exicure has lower revenue, but higher earnings than Atara Biotherapeutics. Atara Biotherapeutics is trading at a lower price-to-earnings ratio than Exicure, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atara Biotherapeutics$128.94M0.83-$85.40M-$0.43-35.53
Exicure$500K64.34-$9.70M-$3.88-1.31

Summary

Atara Biotherapeutics beats Exicure on 11 of the 16 factors compared between the two stocks.

Get Exicure News Delivered to You Automatically

Sign up to receive the latest news and ratings for XCUR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XCUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XCUR vs. The Competition

MetricExicureMED IndustryMedical SectorNASDAQ Exchange
Market Cap$32.22M$3.38B$6.11B$10.47B
Dividend YieldN/A2.29%5.73%4.77%
P/E RatioN/A8.3264.8323.34
Price / Sales64.34488.16608.74136.45
Price / CashN/A46.7037.4661.86
Price / Book4.5410.5512.426.81
Net Income-$9.70M-$52.58M$3.32B$276.80M
7 Day Performance-4.32%1.09%1.01%0.27%
1 Month Performance25.06%16.09%10.75%8.31%
1 Year Performance126.22%18.41%76.20%35.60%

Exicure Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XCUR
Exicure
1.7284 of 5 stars
$5.09
-0.2%
N/A+97.7%$32.22M$500K0.0050
ATRA
Atara Biotherapeutics
4.6017 of 5 stars
$15.20
+8.7%
$21.00
+38.2%
+79.3%$107.41M$128.94M-35.58330Gap Up
MGNX
MacroGenics
4.4364 of 5 stars
$1.70
-3.7%
$3.60
+112.4%
-62.4%$107.14M$149.96M-2.97430Positive News
COYA
Coya Therapeutics
2.4746 of 5 stars
$6.32
-2.8%
$16.20
+156.3%
-8.2%$105.73M$3.55M-5.106
BMEA
Biomea Fusion
3.3299 of 5 stars
$1.77
-33.9%
$9.50
+438.2%
-84.0%$105.63MN/A-0.5950High Trading Volume
WHWK
Whitehawk Therapeutics
1.0207 of 5 stars
$2.23
+3.7%
N/AN/A$105.10M$25.98M-37.1721
HLVX
HilleVax
1.1969 of 5 stars
$2.09
flat
$2.00
-4.3%
N/A$104.79MN/A-1.4620
MEIP
MEI Pharma
0.6485 of 5 stars
$3.19
+14.7%
N/A+19.4%$104.72MN/A-0.67100Gap Up
High Trading Volume
CNTX
Context Therapeutics
3.2332 of 5 stars
$1.15
-5.4%
$5.20
+354.1%
-30.7%$102.71MN/A-3.187Gap Up
ADVM
Adverum Biotechnologies
3.7957 of 5 stars
$4.85
-8.5%
$19.75
+307.2%
-40.6%$101.75M$1M-0.62190
ALXO
ALX Oncology
3.9673 of 5 stars
$1.88
-10.9%
$3.30
+75.5%
+9.7%$100.94MN/A-0.8640

Related Companies and Tools


This page (NASDAQ:XCUR) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners